Progyny officer plans sale of 3,903 shares

The notice reports 76,726,798 Progyny shares outstanding and names Fidelity Brokerage Services LLC as broker.

Available on EDGAR 09/23/2026 - 11:37 AM EDT Accepted by SEC EDGAR 09/23/2026 - 11:36 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Progyny, Inc. (PGNY) reports a proposed sale of 3,903 common shares for Officer Allison C. Swartz, with an aggregate market value of $101,868.30 and an approximate sale date of September 23, 2026. Fidelity Brokerage Services LLC is named as broker. The notice also lists restricted stock vesting entries of 2,398 shares on August 28, 2026, 1,047 shares on September 3, 2026, and 458 shares on September 4, 2026.

Key Figures

Proposed shares for sale: 3,903 common shares Aggregate market value: $101,868.30 Shares outstanding: 76,726,798 shares +3 more

6 metrics

Proposed shares for sale 3,903 common shares Approximate sale date: September 23, 2026

Aggregate market value $101,868.30 Proposed sale

Shares outstanding 76,726,798 shares Progyny

Restricted stock vesting 2,398 shares August 28, 2026

Restricted stock vesting 1,047 shares September 3, 2026

Restricted stock vesting 458 shares September 4, 2026

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Allison C. Swartz"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does PGNY's Form 144 report?

It reports a proposed sale of 3,903 Progyny common shares for Officer Allison C. Swartz, with an approximate sale date of September 23, 2026.

What is the reported value of the proposed PGNY share sale?

The reported aggregate market value is $101,868.30 for the proposed sale of 3,903 common shares.

Who is named in the PGNY sale notice and which broker is listed?

Officer Allison C. Swartz is named as the person for whose account the securities are to be sold. Fidelity Brokerage Services LLC is named as broker.

What restricted stock vesting entries are listed for PGNY?

The notice lists 2,398 shares dated August 28, 2026, 1,047 shares dated September 3, 2026, and 458 shares dated September 4, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001956339
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Progyny, Inc.
SEC File Number	001-39100
Address of Issuer	1359 BROADWAY 2ND FLOOR NEW YORK NEW YORK 10018
Phone	212-888-3124
Name of Person for Whose Account the Securities are To Be Sold	Swartz Allison
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3903	101868.30	76726798	09/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/28/2026	Restricted Stock Vesting	Issuer			2398	09/11/2026	Compensation
Common	09/03/2026	Restricted Stock Vesting	Issuer			1047	09/03/2026	Compensation
Common	09/04/2026	Restricted Stock Vesting	Issuer			458	09/04/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/25/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jared Cook, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Allison C. Swartz
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)